Biomea Fusion, Inc. (NASDAQ:BMEA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bihua Chen Other companies: BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); Helix Acquisition Corp. III (Chairperson and CEO, Director · Since at least Jan 22, 2026); BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Aug 11, 2025) | Director · Since at least Jun 11, 2025 |
| Eric Aguiar Other companies: BridgeBio Pharma, Inc. (Director · Since at least Jun 21, 2024) | Director · Since at least Jun 12, 2024 |
| Franco Valle Other companies: Eidos Therapeutics Inc (Senior Vice President, Finance · Oct 7, 2020 – Jan 26, 2021 · Past) | Chief Financial Officer · Jul 26, 2021 – Nov 30, 2024 · Past |
| Elizabeth Faust | Director · Since at least Jun 22, 2022 |
| Juan Pablo Frias | Chief Medical Officer and Head of Diabetes · Since at least Jun 5, 2026 |
| Julianne Averill | Director · Jul 24, 2025 – Nov 5, 2026 · Past |
| Meichiel Jennifer Weiss | Sr. Director of Investor Relations and Corporate Development · Since at least May 11, 2026 |
| Michael J.M. Hitchcock | Interim Chief Executive Officer and Director · Since at least Mar 25, 2025 |
| Rainer Erdtmann | See Remarks, Director · Since at least Dec 29, 2023 |
| Ramses Erdtmann | Chief Operating Officer and President · Since at least Dec 17, 2024 |
| Sunny Ryan | EVP of Finance · Apr 15, 2021 – Apr 15, 2021 · Past |
| Thomas Butler | Chief Executive Officer, Director · Apr 15, 2021 – Mar 25, 2025 · Past |